Novegent and BMAssay are two new suppliers whose products are now available on antibodies-online. Novegent offers ready-to-use kits as well as different proteins and accessory products: Show all Novegent products . BMAssay offers more than 3.600 ELISA kits and about 500 different proteins: Show all BMAssay products.

The supplier Enogene has expanded their range of products. About 1,000 new antibodies are now available on antibodies-online. Now there are more than 3,000 Enogene products available on our website. Show all Enogene products

Cusabio now offers many new ELISA kits on antibodies-online for a special price until end of May. In addition Cusabio has added many new protocols to help you find the right product for your research. Here you can find all Cusabio ELISA kits

On the way to achieve antibody industrialization, China is faced with challenges in transforming good research into effective products that can be reproduced in large quantities and meet all regulatory and quality standards. The key to overcome above challenges lies in bioprocess.  » Read more

With YueerBio we have added another company offering interesting ELISA kits on antibodies-online.com. The ELISA Kits are especially suited for food safety evaluation. Nearly 40 different ready-to-use kits can now be ordered. »Show all YueerBio kits

New products from Cusabio are available, who expanded his wide range of products even more. About 49.000 new ELISA Kits are available now at antibodies-online.com. »Show all Cusabio kits

SMi’s 2nd annual Biobanking event will reflect the significant change driving current development in bio sample management.  » Read more

As represented by prof. Yamanaka widely known for development of iPS cells, the Japanese academia is rich in bio/pharma-related seeds. Not only drug discovery seeds, various seeds are still hidden in the Japanese academia, such as seeds in early research fields and drug discovery support seeds.  » Read more

Because rare diseases affect only a tiny group of people, pursuing the development of treatments has traditionally not been attractive for pharma companies. However, there are currently lucrative benefits in place set by the regulatory bodies that reward R&D efforts for orphan drugs by ensuring less intense competition, faster and less expensive development, protocol assistance and lower marketing expenses.  » Read more

Antibodies made by the Swedish company Agrisera are especially interesting for scientists from botany, green bioengineering, agriculture and food monitoring.  » Read more

Oxford Global Conferences is proud to present the Biopharma Asia Congress 2012. The congress is the single most focused event in Asia Pacific dedicated to key technological and scientific trends in the Asia Biopharmaceutical industry.  » Read more

Oxford Global Conferences are proud to present the 2nd Annual Vaccines Congress. The conference programme consists of over 35 world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive platform for high-level scientific and business discussions.  » Read more